1. 首页 > 知识问答 > 左室舒张末期内径英文缩写(Left Ventricular End Diastolic Dimension (LVEDD) What You Need to Know)

左室舒张末期内径英文缩写(Left Ventricular End Diastolic Dimension (LVEDD) What You Need to Know)

Left Ventricular End Diastolic Dimension (LVEDD): What You Need to Know

Introduction

The left ventricular end diastolic dimension (LVEDD) is a key measurement used in the assessment of cardiac function, particularly in the diagnosis and management of systolic heart failure. In this article, we will explore what LVEDD is and its significance in cardiovascular health.

What is LVEDD?

LVEDD refers to the measurement of the left ventricle during diastole, or the relaxation phase of the cardiac cycle. It is measured using echocardiography, a non-invasive imaging technique that uses sound waves to create images of the heart. LVEDD is an important indicator of the size and function of the left ventricle, as it reflects the amount of blood that the ventricle can accommodate during diastole.

The Significance of LVEDD in Cardiovascular Health

LVEDD is a crucial parameter in the diagnosis and management of systolic heart failure. In systolic heart failure, the left ventricle is unable to contract and pump blood efficiently, resulting in a decrease in ejection fraction (EF), which is the percentage of blood that is pumped out of the left ventricle with each contraction. A smaller LVEDD indicates reduced ventricular volume and chamber size, which can be seen in patients with heart failure with reduced ejection fraction (HFrEF). LVEDD is also useful in predicting the risk of adverse cardiovascular events, such as heart failure hospitalization and mortality. Studies have shown that a larger LVEDD is associated with an increased risk of cardiovascular events, particularly in patients with HFrEF.

Conclusion

In conclusion, LVEDD plays a critical role in the assessment and management of cardiac function, particularly in patients with systolic heart failure. It is an essential parameter used in the diagnosis and prognostication of HFrEF and in predicting the risk of adverse cardiovascular outcomes. Early identification and management of patients with a larger LVEDD can help reduce the risk of morbidity and mortality associated with heart failure.

版权声明:本文内容由互联网用户自发贡献,该文观点仅代表作者本人。本站仅提供信息存储空间服务,不拥有所有权,不承担相关法律责任。如发现本站有涉嫌抄袭侵权/违法违规的内容, 请发送邮件至3237157959@qq.com 举报,一经查实,本站将立刻删除。

联系我们

工作日:10:00-18:30,节假日休息